3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase 4
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
2
Plasma cell
1
Other hematologic neoplasm
1
Gynecologic
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
60
Leukemia, Myeloid, Acute
40
Leukemia
30
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
28
Hematologic Neoplasms
23
Leukemia, Lymphocytic, Chronic, B-Cell
16
Lymphoma
11
Febrile Neutropenia
10
Myelodysplastic Syndromes
9
Recurrence
8
Neoplasms
8
Lymphoma, Non-Hodgkin
8
Leukemia, Myeloid, Chronic-Phase
8
Leukemia, Promyelocytic, Acute
7
Neoplasm, Residual
6
Neutropenia
5
Neoplasms, Plasma Cell
4
Graft vs Host Disease
4
Philadelphia Chromosome
3
Mycoses
3
Lymphoma, Mantle-Cell
3
Leukemia, B-Cell
3
Invasive Fungal Infections
3
Bronchiolitis Obliterans Syndrome
3
Blast Crisis
3
Waldenstrom Macroglobulinemia
2
Vomiting
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tumor Lysis Syndrome
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Acquired Immunodeficiency Syndrome
×
Other hematologic neoplasm
×
Clear all
NCT04952766
2025-12-23
EREVA
Centre Hospitalier Régional d'Orléans
Phase 4
Completed
196 enrolled